Haemochromatosis gene mutations Cys282Tyr and His63Asp are not increased in Type 2 diabetic patients compared with the Canterbury (New Zealand) general population.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  1999-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8227(98)00129-6PMID 10369430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes.

  1998cited by this paper
• The significance of haemochromatosis gene mutations in the general population: implications for screening.

  1998cited by this paper
• Serum levels of vascular endothelial growth factor in diabetic subjects: the relationship with blood pressure

  1998cited by this paper
• The significance of haemochromatosis gene mutations in the general population: implications for screening

  1998cited by this paper
• Hereditary haemochromatosis mutations (HFE) in patients with Type II diabetes mellitus.

  1998cited by this paper
• Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations.

  1997cited by this paper
• Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosis.

  1997cited by this paper
• A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis

  1996cited by this paper
• Testing for Haemochromatosis in the Diabetic Clinic

  1995cited by this paper
• Preventing Manifestations of Hereditary Haemochromatosis through Population Based Screening

  1994cited by this paper
• Prevalence of Haemochromatosis Amongst Patients with Diabetes Mellitus

  1992cited by this paper
• Screening for Idiopathic Hemochromatosis Among Diabetic Patients

  1991cited by this paper
• Clinical presentation of hemochromatosis: a changing scene.

  1991cited by this paper
• Usefulness of Biochemical Screening of Diabetic Patients for Hemochromatosis

  1990cited by this paper
• Prevalence of genetic haemochromatosis among diabetic patients.

  1989cited by this paper
• Long term results of venesection therapy in idiopathic haemochromatosis.

  1976cited by this paper

• Variations in CCR5, but not HFE, ELMO1, or SLC12A3, are associated with susceptibility to kidney disease in north Indian individuals with type 2 diabetes CCR5变异而不是HFE、ELMO1或者SLC12A3变异与印度北部的2型糖尿病患者的肾病易感性相关

  2014cites this paper
• HFE Gene Mutation Among Turkish Patients with Type 2 Diabetes Mellitus

  2013cites this paper
• Three authors reply.

  2013cites this paper
• Re: "hemochromatosis gene (HFE) polymorphisms and risk of type 2 diabetes mellitus: a meta-analysis".

  2012cites this paper
• Hemochromatosis gene (HFE) polymorphisms and risk of type 2 diabetes mellitus: a meta-analysis.

  2012cites this paper
• Systematic Reviews and Meta-and Pooled Analyses Hemochromatosis Gene ( HFE ) Polymorphisms and Risk of Type 2 Diabetes Mellitus : A Meta-Analysis

  2012influential citation
• Lack of association of C282Y and H63D mutations in the hemochromatosis (HFE) gene with diabetes mellitus type 2 in a case-control study of women in Brazil.

  2009cites this paper
• Dépistage de l'hémochromatose génétique de type I en médecine générale ambulatoire : à propos de deux études pilotes réalisées en Moselle-Est avec recherche des mutations en cas d'élévation de la ferritinémie et du coefficient de saturation de la transferrine

  2008cites this paper
• Hereditary haemochromatosis and diabetes − implications for practice

  2006cites this paper
• HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women.

  2005cites this paper
• Review article: targeted screening for hereditary haemochromatosis in high-risk groups.

  2004cites this paper
• Targeted screening for hereditary haemochromatosis in high‐risk groups

  2004cites this paper
• Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case - control study.

  2003cites this paper
• A relationship between serum ferritin and the insulin resistance syndrome is present in non‐diabetic women but not in non‐diabetic men

  2003cites this paper
• HFE Mutations as risk factors in disease.

  2002cites this paper
• A genetic epidemiologic study of hemochromatosis

  2002cites this paper
• Clinical expression and insulin sensitivity in type 2 diabetic patients with heterozygous mutations for haemochromatosis.

  2002cites this paper
• Hereditary haemochromatosis: only 1% of adult HFE C282Y homozygotes in South Wales have a clinical diagnosis of iron overload

  2002cites this paper
• HFE mutations, iron deficiency and overload in 10 500 blood donors

  2001cites this paper
• [Hereditary hemochromatosis. Case report and review of the literature].

  2001cites this paper
• Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy.

  2001cites this paper
• Hemocromatose hereditária: relato de caso e revisão da literatura

  2001cites this paper
• Perioperative management of a common disorder: hereditary haemochromatosis

  2000cites this paper
• Clinical characteristics of type 2 diabetes in patients with mutations of HFE.

  2000cites this paper